C07F 9/24
Esteramides
C07F9/24 (Esteramides) appears on 803 US grants and 502 published applications in this corpus.
Search patents in C07F- Granted patents
- 803
- Published applications
- 502
- Assignees
- 392
- Inventors
- 1,651
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 46 | 0 |
| 1977 | 26 | 0 |
| 1978 | 29 | 0 |
| 1979 | 23 | 0 |
| 1980 | 27 | 0 |
| 1981 | 20 | 0 |
| 1982 | 8 | 0 |
| 1983 | 16 | 0 |
| 1984 | 14 | 0 |
| 1985 | 23 | 0 |
| 1986 | 18 | 0 |
| 1987 | 8 | 0 |
| 1988 | 10 | 0 |
| 1989 | 8 | 0 |
| 1990 | 8 | 0 |
| 1991 | 6 | 0 |
| 1992 | 10 | 0 |
| 1993 | 17 | 0 |
| 1994 | 6 | 0 |
| 1995 | 11 | 0 |
| 1996 | 19 | 0 |
| 1997 | 16 | 0 |
| 1998 | 16 | 0 |
| 1999 | 18 | 0 |
| 2000 | 13 | 0 |
| 2001 | 15 | 3 |
| 2002 | 11 | 13 |
| 2003 | 12 | 23 |
| 2004 | 15 | 26 |
| 2005 | 10 | 20 |
| 2006 | 16 | 24 |
| 2007 | 17 | 22 |
| 2008 | 12 | 19 |
| 2009 | 15 | 12 |
| 2010 | 22 | 22 |
| 2011 | 12 | 18 |
| 2012 | 15 | 13 |
| 2013 | 12 | 17 |
| 2014 | 24 | 28 |
| 2015 | 18 | 22 |
| 2016 | 18 | 24 |
| 2017 | 19 | 16 |
| 2018 | 18 | 24 |
| 2019 | 16 | 27 |
| 2020 | 18 | 18 |
| 2021 | 16 | 17 |
| 2022 | 16 | 17 |
| 2023 | 10 | 28 |
| 2024 | 15 | 19 |
| 2025 | 7 | 17 |
| 2026 | 8 | 13 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Solid supports and phosphoramidite building blocks for oligonucleotide conjugates15 Sep 2026US 12,735,387 B2AM Chemicals LLC
- Compound containing structure of a heteroaromatic ring, pharmaceutical composition thereof and application thereof16 Jun 2026US 12,655,140 B2Shanghai Yingli Pharmaceutical Co., Ltd
- Probe related reagents and methods2 Jun 2026US 12,643,916 B2Brentano Biotechnology Associates
- Access to chiral bisphenol (BPOL) ligands through desymmetrizing asymmetric ortho-selective mono-halogenation26 May 2026US 12,637,403 B2The Chinese University of Hong Kong
- Anti-inflammatory, anti-cancer, and anti-angiogenic compounds, pharmaceutical compositions, and methods of making and using thereof14 Apr 2026US 12,599,599 B2Medicon Pharmaceuticals, Inc.
- Modulator for promoting binding of butyrophilin 3a1/2a130 Jul 2026US 2026/0216219 A1Unicet Biotech Co. LLC.
- Prodrugs of dimethoxyphenylalkylamine activators of serotonin receptors23 Jul 2026US 2026/0207636 A1
- Combinations treatments2 Jul 2026US 2026/0182577 A1Aequor, Inc.
- Ultra bright dimeric or polymeric dyes2 Jul 2026US 2026/0184926 A1Sony Group Corporation
- Akr1c3-activated dna alkylating agent, and medical application thereof11 Jun 2026US 2026/0159536 A1Ascentawits Pharmaceuticals, Ltd.
Most cited
By later US patents
- Bead linkers for immobilizing nucleic acids to solid supports600US 5,900,481 ASequenom, Inc. · 1999
- Oligonucleotides with selectably cleavable and/or abasic sites574US 5,367,066 AChiron Corporation · 1994
- Phosphoramidite derivatives, their preparation and the use thereof in the incorporation of reporter groups on synthetic oligonucleotides421US 5,567,811 AAmersham International plc · 1996
- Linking reagents for nucleotide probes379US 5,585,481 AGen-Probe Incorporated · 1996
- Amino-derivatized phosphite and phosphate linking agents, phosphoramidite precursors, and useful conjugates thereof308US 4,757,141 AApplied Biosystems, LLC · 1988